IMMU-35. PSYCHOSOCIAL STRESS NEGATIVELY IMPACTS IMMUNOTHERAPY IN IMMUNOCOMPETENT MODELS OF GLIOBLASTOMA

INTRODUCTION: Recent Phase III clinical trial findings indicate a failure of anti-PD-1 mAb (nivolumab) monotherapy to increase overall survival (OS) for recurrent glioblastoma (GBM) patients. Supportingly, we previously demonstrated that, while neither mono- nor dual-therapy with anti-PD-1, radiothe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ladomersky, Erik, Otto-Meyer, Sebastian, Zhai, Lijie, Savoor, Rohan, Lauing, Kristen, Lenzen, Alicia, Amidei, Christina, Lukas, Rimas, Wainwright, Derek
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216331/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.538
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados